rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2000-3-22
|
pubmed:abstractText |
Periodontitis patients harboring Actinobacillus actinmycetemcomitans (Aa) are prime candidates for systemic antibiotic therapy. Besides tetracycline and the combination of metronidazole and amoxicillin the fluoroquinolones are also believed to have antibacterial activity against Aa. The aim of the present study was to evaluate systemic ofloxacin therapy as adjunct to flap surgery.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
D
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-3492
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
202-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10711610-Actinobacillus Infections,
pubmed-meshheading:10711610-Actinobacillus actinomycetemcomitans,
pubmed-meshheading:10711610-Adult,
pubmed-meshheading:10711610-Anti-Infective Agents,
pubmed-meshheading:10711610-Colony Count, Microbial,
pubmed-meshheading:10711610-Dental Plaque,
pubmed-meshheading:10711610-Female,
pubmed-meshheading:10711610-Humans,
pubmed-meshheading:10711610-Male,
pubmed-meshheading:10711610-Ofloxacin,
pubmed-meshheading:10711610-Periodontitis,
pubmed-meshheading:10711610-Single-Blind Method,
pubmed-meshheading:10711610-Statistics, Nonparametric,
pubmed-meshheading:10711610-Treatment Outcome
|
pubmed:year |
2000
|
pubmed:articleTitle |
Fluoroquinolones in the treatment of Actinobacillus actinomycetemcomitans-associated periodontitis.
|
pubmed:affiliation |
Section of Periodontology, College of Dentistry, The Ohio State University, Columbus, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|